These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 38468240)
21. Nrf2-induced miR-23a-27a-24-2 cluster modulates damage repair of intestinal mucosa by targeting the Bach1/HO-1 axis in inflammatory bowel diseases. Dun Su ; Wang X; Ma Y; Hao J; Jinshen Wang ; Yongqu Lu ; Yulin Liu ; Xingfang Wang ; Zhang L Free Radic Biol Med; 2021 Feb; 163():1-9. PubMed ID: 33301881 [TBL] [Abstract][Full Text] [Related]
22. Lnc AC016727.1/BACH1/HIF-1 α signal loop promotes the progression of non-small cell lung cancer. Zhang L; Liang J; Qin H; Lv Y; Liu X; Li Z; Chao Z; Jia C; Qin X; Zhang H J Exp Clin Cancer Res; 2023 Nov; 42(1):296. PubMed ID: 37946265 [TBL] [Abstract][Full Text] [Related]
23. Sugar Free: Novel Immunotherapeutic Approaches Targeting Siglecs and Sialic Acids to Enhance Natural Killer Cell Cytotoxicity Against Cancer. Daly J; Carlsten M; O'Dwyer M Front Immunol; 2019; 10():1047. PubMed ID: 31143186 [TBL] [Abstract][Full Text] [Related]
24. [miR-155/BACH1 Signaling Pathway in Human Lung Adenocarcinoma Cell Death Induced by Arsenic Trioxide]. Gu SY; Chen HY; Dai HM; Li XY; Zhang ZZ Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Nov; 48(6):828-833. PubMed ID: 29260515 [TBL] [Abstract][Full Text] [Related]
25. Sialic Acid-Siglec Axis as Molecular Checkpoints Targeting of Immune System: Smart Players in Pathology and Conventional Therapy. Wielgat P; Rogowski K; Niemirowicz-Laskowska K; Car H Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575400 [TBL] [Abstract][Full Text] [Related]
26. Disruption of the sialic acid/Siglec-9 axis improves antibody-mediated neutrophil cytotoxicity towards tumor cells. Lustig M; Chan C; Jansen JHM; Bräutigam M; Kölling MA; Gehlert CL; Baumann N; Mester S; Foss S; Andersen JT; Bastian L; Sondermann P; Peipp M; Burger R; Leusen JHW; Valerius T Front Immunol; 2023; 14():1178817. PubMed ID: 37346044 [TBL] [Abstract][Full Text] [Related]
27. Circular RNA circ_0000337 contributes to osteosarcoma via the miR-4458/BACH1 pathway. Fang Y; Long F Cancer Biomark; 2020; 28(4):411-419. PubMed ID: 32390598 [TBL] [Abstract][Full Text] [Related]
28. Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer. Läubli H; Pearce OM; Schwarz F; Siddiqui SS; Deng L; Stanczak MA; Deng L; Verhagen A; Secrest P; Lusk C; Schwartz AG; Varki NM; Bui JD; Varki A Proc Natl Acad Sci U S A; 2014 Sep; 111(39):14211-6. PubMed ID: 25225409 [TBL] [Abstract][Full Text] [Related]
29. Siglecs-7/9 function as inhibitory immune checkpoints in vivo and can be targeted to enhance therapeutic antitumor immunity. Ibarlucea-Benitez I; Weitzenfeld P; Smith P; Ravetch JV Proc Natl Acad Sci U S A; 2021 Jun; 118(26):. PubMed ID: 34155121 [TBL] [Abstract][Full Text] [Related]
30. GATA3 Encapsulated by Tumor-Associated Macrophage-Derived Extracellular Vesicles Promotes Immune Escape and Chemotherapy Resistance of Ovarian Cancer Cells by Upregulating the CD24/Siglec-10 Axis. Chen C; Zhang L; Ruan Z Mol Pharm; 2023 Feb; 20(2):971-986. PubMed ID: 36547230 [TBL] [Abstract][Full Text] [Related]
31. LncRNA SNHG5 promotes the glycolysis and proliferation of breast cancer cell through regulating BACH1 via targeting miR-299. Huang SL; Huang ZC; Zhang CJ; Xie J; Lei SS; Wu YQ; Fan PZ Breast Cancer; 2022 Jan; 29(1):65-76. PubMed ID: 34351577 [TBL] [Abstract][Full Text] [Related]
32. LncRNA PVT1 accelerates malignant phenotypes of bladder cancer cells by modulating miR-194-5p/BCLAF1 axis as a ceRNA. Chen M; Zhang R; Lu L; Du J; Chen C; Ding K; Wei X; Zhang G; Huang Y; Hou J Aging (Albany NY); 2020 Nov; 12(21):22291-22312. PubMed ID: 33188158 [TBL] [Abstract][Full Text] [Related]
33. Long Noncoding RNA X-Inactive Specific Transcript Regulates Neuronal Cell Apoptosis in Ischemic Stroke Through miR-98/BACH1 Axis. Weng S; Wang S; Jiang J DNA Cell Biol; 2021 Jul; 40(7):979-987. PubMed ID: 34227845 [TBL] [Abstract][Full Text] [Related]
34. Novel Siglec-15-Sia axis inhibitor leads to colorectal cancer cell death by targeting miR-6715b-3p and oncogenes. Ahmad MS; Braoudaki M; Patel H; Ahmad I; Shagufta ; Siddiqui SS Front Immunol; 2023; 14():1254911. PubMed ID: 37869015 [TBL] [Abstract][Full Text] [Related]
35. SIGLEC-5/14 Inhibits CD11b/CD18 Integrin Activation and Neutrophil-Mediated Tumor Cell Cytotoxicity. Bouti P; Blans C; Klein BJAM; Shome D; Nadafi R; Van Houdt M; Schornagel K; Verkuijlen PJJH; Roos V; Reijmers RM; Van Bruggen R; Kuijpers TW; Matlung HL Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38138970 [TBL] [Abstract][Full Text] [Related]
36. Quantitative assessment of Siglec-15 expression in lung, breast, head, and neck squamous cell carcinoma and bladder cancer. Shafi S; Aung TN; Xirou V; Gavrielatou N; Vathiotis IA; Fernandez A; Moutafi M; Yaghoobi V; Herbst RS; Liu LN; Langermann S; Rimm DL Lab Invest; 2022 Oct; 102(10):1143-1149. PubMed ID: 35581307 [TBL] [Abstract][Full Text] [Related]
37. Tumor cell-intrinsic and tumor microenvironmental conditions co-determine signaling by the glycoimmune checkpoint receptor Siglec-7. van Houtum EJH; Kers-Rebel ED; Looman MW; Hooijberg E; Büll C; Granado D; Cornelissen LAM; Adema GJ Cell Mol Life Sci; 2023 May; 80(6):169. PubMed ID: 37253806 [TBL] [Abstract][Full Text] [Related]
38. The long noncoding RNA LINC01140/miR-140-5p/FGF9 axis modulates bladder cancer cell aggressiveness and macrophage M2 polarization. Wu S; Xu R; Zhu X; He H; Zhang J; Zeng Q; Wang Y; Zhao X Aging (Albany NY); 2020 Nov; 12(24):25845-25864. PubMed ID: 33234721 [TBL] [Abstract][Full Text] [Related]
39. LINC00973 is involved in cancer immune suppression through positive regulation of Siglec-15 in clear-cell renal cell carcinoma. Liu Y; Li X; Zhang C; Zhang H; Huang Y Cancer Sci; 2020 Oct; 111(10):3693-3704. PubMed ID: 32780490 [TBL] [Abstract][Full Text] [Related]
40. Exosomes derived from mesenchyml stem cells ameliorate oxygen-glucose deprivation/reoxygenation-induced neuronal injury via transferring MicroRNA-194 and targeting Bach1. Li X; Zhang X; Liu Y; Pan R; Liang X; Huang L; Yang C Tissue Cell; 2021 Dec; 73():101651. PubMed ID: 34600339 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]